{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-269650","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2026-06-12T21:01:14+00:00","discovered_at":"2026-06-12T21:02:00.231051+00:00","generated_at":"2026-06-12T21:02:25.491750+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Apogee shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting","bullets":["Director nominees Mark C. McKenna, Jennifer Fox, William Jones elected with >44.9M votes each, broker non-votes 1.8M.","Ratification of Ernst & Young as independent auditor for FY2026: 56.96M for, 1,361 against.","Non-binding advisory vote on named executive officer compensation: 54.32M for, 634k against, 247k abstentions.","All three proposals passed; no material changes to board composition or corporate governance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-269650","json":"https://secwatch.observer/filing/0001193125-26-269650.json","markdown":"https://secwatch.observer/filing/0001193125-26-269650.md","text":"https://secwatch.observer/filing/0001193125-26-269650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:02:25.491750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"47927d267b5d255cf2f3b2cb93b794f5d4a8b41c","claim":"Apogee Therapeutics, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-09 meeting.","evidence_excerpt":"The compensation of our named executive officers as disclosed in the Proxy Statement was approved on a non-binding, advisory basis as follows: Votes For Votes Against Abstentions Broker Non-Votes 54,324,725 633,959 246,567 1,795,532","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"5b2d281ad34916d113246b43447bab9d4a12528c","claim":"Apogee Therapeutics, Inc. shareholders approved Election of Class III directors at the 2026-06-09 meeting.","evidence_excerpt":"The following Class III director nominees were elected to serve until the 2029 Annual Meeting of Stockholders based upon the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Mark C. McKenna 53,689,547 1,515,704 1,795,532 Jennifer Fox 52,895,552 2,309,699 1,795,532 William (BJ) Jones, Jr. 44,964,804 10,240,447 1,795,532","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"8829f3c73d8a3d96fdf152b844be7f8c7bb5abe4","claim":"Apogee Therapeutics, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-09 meeting.","evidence_excerpt":"The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified as follows: Votes For Votes Against Abstentions 56,960,778 1,361 38,644","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}